When compared with lung cancer lymph node metastasis, the CD4/CD8 ratio was significantly higher in sarcoidosis, whereas the CD3/CD19 ratio was significantly higher in lung cancer. This evidence concerns the gene CD19 and metastatic malignant neoplasm in the lymph nodes.